Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1456]

Five factors identify subset of patients with advanced cervical cancer who may not benefit from bevacizumab treatment

Five factors identify subset of patients with advanced cervical cancer who may not benefit from bevacizumab...

Probing the mystery of how cancer cells die

Probing the mystery of how cancer cells die

Largest ever ovarian cancer trial suggests that screening reduces mortality, but longer follow-up is needed

Largest ever ovarian cancer trial suggests that screening reduces mortality, but longer follow-up is needed

Study suggests that annual CA125 screening may reduce ovarian cancer deaths

Study suggests that annual CA125 screening may reduce ovarian cancer deaths

Research reveals promising novel strategy to target cancer-causing protein

Research reveals promising novel strategy to target cancer-causing protein

Newer cancer drug may help protect kidneys from damage caused by older drug

Newer cancer drug may help protect kidneys from damage caused by older drug

Continuous joint use of oestrogen and progestin lowers risk of EC in postmenopausal women

Continuous joint use of oestrogen and progestin lowers risk of EC in postmenopausal women

Fallopian tube organoids promise better understanding of ovarian cancer and infertility

Fallopian tube organoids promise better understanding of ovarian cancer and infertility

Cancer rates decline in many high-income countries, but rise in lower-income countries

Cancer rates decline in many high-income countries, but rise in lower-income countries

NICE give go ahead for olaparib and enzalutamide, but not abiraterone

NICE give go ahead for olaparib and enzalutamide, but not abiraterone

More from ecancer